UB Paderborn / Katalog / Suche / in CDI

A Comparison of Spatial and Phenotypic Immune Profiles of Pancreatic Ductal Adenocarcinoma and Its Precursor Lesions

International journal of molecular sciences, 2024-03, Vol.25 (5), p.2953

2024

Link zum Volltext

Verfügbarkeit prüfen

Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology

Journal of the National Comprehensive Cancer Network, 2022-02, Vol.20 (2), p.167

2022

Link zum Volltext

Verfügbarkeit prüfen

B-cell activating factor and v-Myc myelocytomatosis viral oncogene homolog (c-Myc) influence progression of chronic lymphocytic leukemia

Proceedings of the National Academy of Sciences - PNAS, 2010-11, Vol.107 (44), p.18956-18960

2010

Link zum Volltext

Verfügbarkeit prüfen

Kinase MEKK1 is required for CD40 -dependent activation of the kinases Jnk and p38 , germinal center formation, B cell proliferation and antibody production

Nature Immunology, 2007-01, Vol.8 (1), p.57-63

2007

Link zum Volltext

Verfügbarkeit prüfen

Long-acting somatostatin analogues in the treatment of unresectable/metastatic neuroendocrine tumors

Seminars in oncology, 2017-04, Vol.44 (2), p.141-156

2017

Link zum Volltext

Verfügbarkeit prüfen

Clinical Trials in Pancreatic Cancer: A Long Slog

The oncologist (Dayton, Ohio), 2017-12, Vol.22 (12), p.1424-1426

2017

Link zum Volltext

Verfügbarkeit prüfen

MEKK1 Binds HECT E3 Ligase Itch by Its Amino-Terminal RING Motif to Regulate Th2 Cytokine Gene Expression

The Journal of immunology (1950), 2009-09, Vol.183 (6), p.3831-3838

2009

Link zum Volltext

Verfügbarkeit prüfen

Combining chemotherapy with PD-1 blockade in NSCLC

Pharmacology & therapeutics (Oxford), 2018-06, Vol.186, p.130-137

2018

Link zum Volltext

Verfügbarkeit prüfen

872 Neoadjuvant chemoradiotherapy enhances T cell infiltration in pancreatic ductal adenocarcinoma but high percentage of regulatory T cells associates with poor survival

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A517-A518

2020

Link zum Volltext

Verfügbarkeit prüfen

Phase 2 multicenter trial of rucaparib and nivolumab as maintenance therapy following first-line platinum-based chemotherapy in patients with advanced biliary tract cancer (BTC): BilT-02

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.4113-4113

2023

Link zum Volltext

Verfügbarkeit prüfen

A phase I/II trial to evaluate cabozantinib in patients with advanced hepatocellular carcinoma with Child-Pugh class B cirrhosis after first-line therapy

Journal of clinical oncology, 2021-01, Vol.39 (3_suppl), p.TPS357-TPS357

2021

Link zum Volltext

Verfügbarkeit prüfen

Phase 1b results of a multicenter, randomized phase 1b/2 study of gemcitabine and cisplatin +/- CPI-613 as first-line therapy for patients with advanced biliary tract cancer (BilT-04)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.4094-4094

2022

Link zum Volltext

Verfügbarkeit prüfen

Emerging antibody therapies for pancreatic adenocarcinoma: a review of recent phase 2 trials

Expert opinion on emerging drugs, 2021-04, Vol.26 (2), p.103-129

2021

Link zum Volltext

Verfügbarkeit prüfen

Prostate Cancer-Associated Disseminated Intravascular Coagulation with Excessive Fibrinolysis Treated with Degarelix

Case reports in oncological medicine, 2015-01, Vol.2015, p.212543-6

2015

Link zum Volltext

Verfügbarkeit prüfen

A multicenter phase Ib/II study of liposomal-irinotecan, 5-fluorouracil (5-FU), and leucovorin (LV) with nivolumab as second-line therapy for patients with advanced biliary tract cancer (BilT-03)

Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.438-438

2022

Link zum Volltext

Verfügbarkeit prüfen

Devimistat in combination with gemcitabine and cisplatin in biliary tract cancer: Pre-clinical evaluation and phase 1b multicenter clinical trial (BilT-04)

Clinical cancer research, 2023-07, Vol.29 (13), p.2394-2400

2023

Link zum Volltext

Verfügbarkeit prüfen

BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-κB pathway

Blood, 2007-01, Vol.109 (2), p.703-710

2007

Link zum Volltext

Verfügbarkeit prüfen

Devimistat in Combination with Gemcitabine and Cisplatin in Biliary Tract Cancer: Preclinical Evaluation and Phase Ib Multicenter Clinical Trial (BilT-04)

Clinical cancer research, 2023-07, Vol.29 (13), p.2394-2400

2023

Link zum Volltext

Verfügbarkeit prüfen

Impact of microsatellite instability status and sidedness of the primary tumor on immunophenotype of colorectal cancer

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e15664-e15664

2018

Link zum Volltext

Verfügbarkeit prüfen

IL-1β-driven neutrophilia preserves antibacterial defense in the absence of the kinase IKKβ

Nature immunology, 2011-02, Vol.12 (2), p.144

2011

Link zum Volltext

Verfügbarkeit prüfen

The Role of Oncolytic Viruses in the Treatment of Melanoma

Current oncology reports, 2018-10, Vol.20 (10), p.80-14, Article 80

2018

Link zum Volltext

Verfügbarkeit prüfen

Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology

Journal of the National Comprehensive Cancer Network, 2023-04, Vol.21 (4), p.393

2023

Link zum Volltext

Verfügbarkeit prüfen

Quantitative multiplex immune fluorescence to reveal the impact of chemoradiation therapy on modulation of the immune micro-environment of pancreatic ductal adenocarcinoma

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.4122-4122

2018

Link zum Volltext

Verfügbarkeit prüfen

Epithelial Control of Gut-Associated Lymphoid Tissue Formation through p38α-Dependent Restraint of NF-κB Signaling

The Journal of immunology (1950), 2016-03, Vol.196 (5), p.2368-2376

2016

Link zum Volltext

Verfügbarkeit prüfen

Alternative and Classical NF-κB Signaling Retain Autoreactive B Cells in the Splenic Marginal Zone and Result in Lupus-like Disease

Immunity (Cambridge, Mass.), 2006-09, Vol.25 (3), p.403-415

2006

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

A Comparison of Spatial and Phenotypic Immune Profiles of Pancreatic Ductal Adenocarcinoma and Its Precursor Lesions

Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology

B-cell activating factor and v-Myc myelocytomatosis viral oncogene homolog (c-Myc) influence progression of chronic lymphocytic leukemia

Kinase MEKK1 is required for CD40 -dependent activation of the kinases Jnk and p38 , germinal center formation, B cell proliferation and antibody production

Long-acting somatostatin analogues in the treatment of unresectable/metastatic neuroendocrine tumors

Clinical Trials in Pancreatic Cancer: A Long Slog

MEKK1 Binds HECT E3 Ligase Itch by Its Amino-Terminal RING Motif to Regulate Th2 Cytokine Gene Expression

Combining chemotherapy with PD-1 blockade in NSCLC

872 Neoadjuvant chemoradiotherapy enhances T cell infiltration in pancreatic ductal adenocarcinoma but high percentage of regulatory T cells associates with poor survival

Phase 2 multicenter trial of rucaparib and nivolumab as maintenance therapy following first-line platinum-based chemotherapy in patients with advanced biliary tract cancer (BTC): BilT-02

A phase I/II trial to evaluate cabozantinib in patients with advanced hepatocellular carcinoma with Child-Pugh class B cirrhosis after first-line therapy

Phase 1b results of a multicenter, randomized phase 1b/2 study of gemcitabine and cisplatin +/- CPI-613 as first-line therapy for patients with advanced biliary tract cancer (BilT-04)

Emerging antibody therapies for pancreatic adenocarcinoma: a review of recent phase 2 trials

Prostate Cancer-Associated Disseminated Intravascular Coagulation with Excessive Fibrinolysis Treated with Degarelix

A multicenter phase Ib/II study of liposomal-irinotecan, 5-fluorouracil (5-FU), and leucovorin (LV) with nivolumab as second-line therapy for patients with advanced biliary tract cancer (BilT-03)

Devimistat in combination with gemcitabine and cisplatin in biliary tract cancer: Pre-clinical evaluation and phase 1b multicenter clinical trial (BilT-04)

BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-κB pathway

Devimistat in Combination with Gemcitabine and Cisplatin in Biliary Tract Cancer: Preclinical Evaluation and Phase Ib Multicenter Clinical Trial (BilT-04)

Impact of microsatellite instability status and sidedness of the primary tumor on immunophenotype of colorectal cancer

IL-1β-driven neutrophilia preserves antibacterial defense in the absence of the kinase IKKβ

The Role of Oncolytic Viruses in the Treatment of Melanoma

Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology

Quantitative multiplex immune fluorescence to reveal the impact of chemoradiation therapy on modulation of the immune micro-environment of pancreatic ductal adenocarcinoma

Epithelial Control of Gut-Associated Lymphoid Tissue Formation through p38α-Dependent Restraint of NF-κB Signaling

Alternative and Classical NF-κB Signaling Retain Autoreactive B Cells in the Splenic Marginal Zone and Result in Lupus-like Disease

Suchergebnisse filtern